InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 332234

Wednesday, 11/06/2019 3:06:35 PM

Wednesday, November 06, 2019 3:06:35 PM

Post# of 345952

Coming for your CDMO shares :) just as Laura Benjamin is scheduled to speak at SITC 2019 Nov 6-10 ....


Laura Benjamin - CEO Oncologie Inc re: PS Targeting biomarkers Avid Bioservices CDMO

https://podcasts.apple.com/us/podcast/laura-benjamin-oncologie-part-of-the-nametag-series/id1088325796?i=1000450524353



Who listened to PS Targeting IP asset to Avid Bioservices CDMO CEO Laura Benjamin yet? ...27 minutes .. longer than the Avid BOD boys can talk and makes John Springs Stafford sound a bit foolish, now....he must have been working for some other party.

She speaks openly about the IP assets and more : ) ....someone today must have realized this info is getting out to NEW IIS

Laura Benjamin at the end of the interview...just admitted Bavituximab treated patients are LIVING longer : )

She called the other IP asset to Avid CDMO where royalties will come and manufacturing ...a best in class VEGF

John Stafford lied, stole and helped shift the IP to Oncologie ...didn't he ?

Dr Benjamin verified she will be presenting at SITC 2019 and ALL good words she spoke of the IP assets

Congratulations to extended MOS to Merck Keytruda patents ....as it was Bavituximab that allowed for the MOS survival, NOT Keytruda
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News